Skip to main content
 

Rare Diseases NHS Update

06 Oct 2022 13:00 - 14:00

Rare Diseases NHS Update
Click to enlarge

I am the founder of Oxygen - a strategic healthcare public affairs company based in the new diplomatic precinct of Nine Elms in London.

more about Henry

Shailen has had a leading involvement in well over 300 partnership working projects over his career - initially working in the NHS and latterly under the banner of Soar Beyond Ltd

more about Shailen

A pharmaceutical market access specialist with more than 20 years’ experience of tracking access environments around the world. 

more about Neil
THINK TANK - OCTOBER EDITION

Treatment and funding decisions for rare diseases have in the main shifted from NHS England to integrated care systems (ICSs). Much more than a simple change in policy, the intention is to create an integrated and cooperative system of care that operated at pan-ICS and individual levels.

How should companies who provide pharmaceuticals and technologies for this specialised area of medicine respond to this paradigm-shift in policy?

In October's FREE 60-minute LIVE Think Tank , our experts will explain how the new system operates, what will change and how you can become a part of the rare diseases new world, working with your customers to maximise opportunities and outcomes.

 

Discover:

  • How rare diseases will be managed in the ICS-era
  • How to engage with the new system
  • The key players and decision makers
  • Where resources will be allocated

 

 

Sign up using the form below: